PURPOSE: The aim of the study was to evaluate the association between coffee consumption and mortality from liver cirrhosis. METHODS: We conducted a mortality follow-up of 51,306 adults who underwent screening for cardiovascular disease from 1977 to 1983. During the subsequent 17 years, the total number of deaths from all causes in the studied cohort was 4207. Fifty-three had the diagnosis of cirrhosis mentioned on the death certificate; of these, 36 had alcoholic cirrhosis. RESULTS: The relative risk of liver cirrhosis mentioned on the death certificate associated with an increase of two cups of coffee, adjusted for sex, age, alcohol use and other major cardiovascular risk factors was 0.6 (95% confidence interval, 0.5-0.8). For alcoholic cirrhosis the results were identical. When studying cirrhosis as the underlying cause of death, the inverse relationship becomes somewhat stronger. CONCLUSIONS: The present study confirms the existence of an inverse association between coffee consumption and liver cirrhosis.
PURPOSE: The aim of the study was to evaluate the association between coffee consumption and mortality from liver cirrhosis. METHODS: We conducted a mortality follow-up of 51,306 adults who underwent screening for cardiovascular disease from 1977 to 1983. During the subsequent 17 years, the total number of deaths from all causes in the studied cohort was 4207. Fifty-three had the diagnosis of cirrhosis mentioned on the death certificate; of these, 36 had alcoholic cirrhosis. RESULTS: The relative risk of liver cirrhosis mentioned on the death certificate associated with an increase of two cups of coffee, adjusted for sex, age, alcohol use and other major cardiovascular risk factors was 0.6 (95% confidence interval, 0.5-0.8). For alcoholic cirrhosis the results were identical. When studying cirrhosis as the underlying cause of death, the inverse relationship becomes somewhat stronger. CONCLUSIONS: The present study confirms the existence of an inverse association between coffee consumption and liver cirrhosis.
Authors: Mario G Moreno; Enrique Chávez; Liseth R Aldaba-Muruato; José Segovia; Paula Vergara; Víctor Tsutsumi; Mineko Shibayama; Yadira Rivera-Espinoza; Pablo Muriel Journal: Hepatol Int Date: 2011-01-25 Impact factor: 6.047
Authors: Craig Lammert; Brian D Juran; Erik Schlicht; Xiao Xie; Elizabeth J Atkinson; Mariza de Andrade; Konstantinos N Lazaridis Journal: Clin Gastroenterol Hepatol Date: 2014-01-16 Impact factor: 11.382
Authors: Ming Ding; Ambika Satija; Shilpa N Bhupathiraju; Yang Hu; Qi Sun; Jiali Han; Esther Lopez-Garcia; Walter Willett; Rob M van Dam; Frank B Hu Journal: Circulation Date: 2015-11-16 Impact factor: 29.690
Authors: Neal D Freedman; James E Everhart; Karen L Lindsay; Marc G Ghany; Teresa M Curto; Mitchell L Shiffman; William M Lee; Anna S Lok; Adrian M Di Bisceglie; Herbert L Bonkovsky; John C Hoefs; Jules L Dienstag; Chihiro Morishima; Christian C Abnet; Rashmi Sinha Journal: Hepatology Date: 2009-11 Impact factor: 17.425
Authors: Veronica Wendy Setiawan; Lynne R Wilkens; Shelly C Lu; Brenda Y Hernandez; Loïc Le Marchand; Brian E Henderson Journal: Gastroenterology Date: 2014-10-08 Impact factor: 22.682
Authors: Apurva A Modi; Jordan J Feld; Yoon Park; David E Kleiner; James E Everhart; T Jake Liang; Jay H Hoofnagle Journal: Hepatology Date: 2010-01 Impact factor: 17.425